The present study, showing that silencing of KGFR affects proliferation, motility and response of tumor-derived cell lines to chemotherapeutic drugs, such as 5-FU and tamoxifen, seems to indicate that KGFR may represent an important target for the development of novel therapeutic strategies. The gene discussed is FGFR2; the disease is neoplasm.